期刊文献+

敲除小鼠足细胞核因子-κB受体活化因子基因对尿蛋白的影响 被引量:2

Effects of knockout receptor activator of NF-κB (RANK) in podocytes on proteinuria in mice
原文传递
导出
摘要 目的探讨核因子-κB受体活化因子(RANK)在足细胞损伤中的作用及其对蛋白尿的影响。方法用Cre-LoxP重组酶系统建立足细胞RANK特异性敲除小鼠(RANK-/-,KO组),琼脂糖电泳法鉴定其基因型。设野生型小鼠(wT)和普通C57小鼠(各6只)为对照组。用脂多糖(LPS)腹腔注射方法建立短暂蛋白尿小鼠模型。检测各组小鼠尿白蛋白,尿肌酐等指标;模型建立后48h处死小鼠取肾脏行病理检查。免疫组化法检测肾脏足细胞数量;电镜下观察足细胞足突融合情况;免疫荧光法检测整合素(integrin)β1及integrinβ3等相关蛋白表达变化;Western印迹法检测integrinβ1、integrinβ3及尿激酶型纤溶酶原激活物受体(uPAR)等相关蛋白的表达变化。结果3组小鼠均于造模后第2天出现明显蛋白尿,KO组小鼠尿白蛋白/肌酐比值明显低于对照组wT组及C57组[(23.70±9.90)比(107.56±22.32);(23.70±9.90)比(132.13±14.26),P〈0.0011,差异有统计学意义。免疫组化结果显示,造模后3组小鼠足细胞数量均有减少,KO组小鼠足细胞减少程度比其他两组轻。电镜结果亦显示,造模后KO组小鼠足细胞足突融合程度较对照组轻。免疫荧光结果显示,与造模前组相比,造模后各组小鼠肾组织integrinpl表达均有下降,KO组较对照组下降幅度更大;integrinB3表达升高,KO组升高幅度较对照组较少(均P〈0.05)。Western印迹结果显示,与造模前组相比,造模后各组小鼠。肾组织integrinB1表达均下降,KO组小鼠下降幅度更大;各组小鼠integrinB3及uPAR表达均升高,KO组升高幅度较其余两组较小(均P〈0.05)。结论敲除小鼠足细胞特异性RANK基因后可以减少LPS诱导的蛋白尿,提示RANK参与了由足细胞损伤导致蛋白尿的发生,其机制与调节integfinpl,integrin β3及uPAR等分子的表达有关。 Objective To investigate the role of RANK in injured podocyte and its effects on proteinuria. Methods PCR analysis was carried out to identify the genotypes of podocyte-specific RANK knockout mice. Six (6-8 weeks old) female RANK-/- mice were chosen as KO group. Six (6-8 weeks old) littermates and six (6-8 weeks old) C57/B6j mice were chosen as WT group and C57 group respectively. Each group was injected with LPS to create podocyte-injured proteinuria model. 24h urine was collected before and after injection. Urinary albumin, urine creatinine and UACR were detected by automatic biochemical analyzer. The mice were sacrificed after 48 h. Cortical kidney tissue samples were stained by PAS and collected for transmission electron microscopy to detect the foot process effacement. The number of podocytes was examined at different time points by immunohistochemistry . The expression of intergrin-β1, integrin- β3 and uPAR was detected by immunofluorescence and westernblot. Results (1) Comparing KO group, WT group and C57 group, it was found that there was no difference in weight, morphology, function of kidney and ACR. (2) After LPS injection, proteinuria and ACR were increased in three groups, but less significantly in KO group (23.70±9.90), compared to those in WT group (107.56±22.32) and C57 group (132.13±14.26) (P 〈 0.001). (3) In three groups, the number of podocytes was decreased after LPS injection and the decrease in the KO group was the slightest. (4) Compared to WT and C57 group, podocyte foot process effacement was less obvious in KO group after LPS injection in transmission electron microscopy. (5) Immunofluorescence results showed that after LPS injection, integrin-β1 was decreased in three groups, but most significantly in KO group. Integrin-β3 was increased in three groups, but less obvious in KO group. (6) Westernblot results showed consistency with immunofluorescence. The expression of uPAR protein was increased in three groups, with the increase in KO group being the slightest. Conclusions Podocytespecific knockout of RANK reduces LPS-induced proteinuria, suggesting that RANK might be involved in the development of proteinuria in podocyt injury. Its mechanism is probably related with integrin-β1, integrin-β3 and uPAR.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2016年第3期187-194,共8页 Chinese Journal of Nephrology
基金 “十二五”国家科技支撑计划项目(2011BAI10B06) 国家自然科学基金项目(81470930,81370808) 广东省自然科学基金(2014A030313544) 广州市科技计划攻关项目(2012J4300084)
关键词 足细胞 小鼠 基因敲除 脂多糖类 核因子.KB受体活化因子 Podocyte Mice, knockout Lipopolysaccharides Receptor activator of nuclear factor-kappa B
  • 相关文献

参考文献18

  • 1Lasagni L, Romagnani P. Glomerular epithelial stem cells: the good, the bad, and the ugly[J]. J Am Soc Nephro, 2010, 21(10): 1612-1619.
  • 2Gonzalez- Suarez E, Jacob AP, Jones J, et al. RANK ligand mediates progestin- induced mammary epithelial proliferation and carcinogenesis[J]. Nature, 2010, 468(7320): 103- 107.
  • 3Osorio A, Ortega E, Terres JM, et al. Mineral-bone metabolism markers in young hemodialysis patients[J].. Clin Bioehem, 2011, 44(17- 18): 1425 - 1428.
  • 4Ozkok A, Caliskan Y, Sakaci T, et al. Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients[J]. Clin J Am Soc Nephrolm, 2012, 7(6): 965-973.
  • 5Romas E, Sims NA, Hards DK, et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen- induced arthritis[J]. Am J Pathol, 2002, 161(4): 1419-1427.
  • 6Fata JE, Kong YY, Li J, et al. The osteoclast differentiation factor osteoprotegerin- ligand is essential for mammary gland development[J]. Cell, 2000, 103(1): 41-50.
  • 7Gonzalez- Suarez E, Jacob AP, Jones J, et al. RANK ligand mediates progestin- induced mammary epithelial proliferation andcarcinogenesis[J]. Nature, 2010, 468(7321): 103-107.
  • 8Beleut M, Rajaram RD, Caikovski M, et al. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland[J]. Proc Natl Aead Sei US, 2010, 107(7): 2989- 2994.
  • 9冯仲林,刘双信,史伟,肖厚勤,梁馨苓,刘晓颖,叶智明,王素霞,梁永正,章斌,王文健,刘艳辉,梅平,徐丽霞,马建超,夏运风.嘌呤霉素氨基核苷肾病肾脏中RANK-RANKL的表达[J].南方医科大学学报,2014,34(1):65-69. 被引量:8
  • 10刘双信,史伟,梁馨苓,李珩,叶智明,王文健,何朝生,梁永正,刘艳辉,胡湘明,章斌,彭炎强,余细勇.核因子κB受体活化因子及其配体在5/6肾切除大鼠肾脏中表达及缬沙坦对其影响[J].中华肾脏病杂志,2006,22(7):421-425. 被引量:7

二级参考文献28

  • 1李振勇,倪兆慧.足细胞损伤的干预研究进展[J].国际泌尿系统杂志,2006,26(4):547-550. 被引量:4
  • 2刘双信,史伟,梁馨苓,李珩,叶智明,王文健,何朝生,梁永正,刘艳辉,胡湘明,章斌,彭炎强,余细勇.核因子κB受体活化因子及其配体在5/6肾切除大鼠肾脏中表达及缬沙坦对其影响[J].中华肾脏病杂志,2006,22(7):421-425. 被引量:7
  • 3Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density.Cell,1997,89:309-319.
  • 4Yang N,Wu LL,Nikolic-Paterson DJ,et al.Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney.Nephrol Dial Transplant,1998,13:1967-1974.
  • 5Wu LL,Yang N,Roe CJ,et al.Macrophage and myofibroblast proliferation in remnant kidney:Role of angiotensin Ⅱ.Kidney Int,1997,63 Suppl:S221 -S225.
  • 6Fujihara CK,De Lourdes Noronha I,Malheiros DM,et al.Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney.J Am Soc Nephrol,2000,11:283-290.
  • 7Franchimont N,Reenaers C,Lambert C,et al.Increased expression of receptor activator of NF-kappa B ligand (RANKL),its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients.Clin Exp Immunol,2004,138:491-498.
  • 8Hofbauer LC,Kluger S,Kuhne CA,et al.Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.J Cell Biochem,2002,86:642-650.
  • 9Romas E,Sims NA,Hards DK,et al.Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.Am J Pathol,2002,161:1419-1427.
  • 10Wong BR,Josien R,Lee Sy,et al.TRANCE (Tumor Necrosis Factor[TNF]-related activation-inducedcytokine),a new TN F family member predominantly expressed in T cells,is a dendritic cell-specific survival factor.J Exp Med,1997,186:2075-2080.

共引文献10

同被引文献22

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部